A. Mervoyer

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial

Sylvie Bonvalot, Piotr Rutkowski, Juliette Thariat et al. · The Lancet Oncology · 2019 · 469 citations · Full text

Radiation Medicine, Radiation Therapy, Medicine +10

Performance comparison of modified ComBat for harmonization of radiomic features for multicenter studies

Ronrick Da‐ano, Ingrid Masson, François Lucia et al. · Scientific Reports · 2020 · 186 citations · Full text

External validation of a combined PET and MRI radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapy

François Lucia, Dimitris Visvikis, Martin Vallières et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 176 citations

Adaptive Radiotherapy, Combined Pet, External Validation +13

A transfer learning approach to facilitate ComBat-based harmonization of multicentre radiomic features in new datasets

Ronrick Da‐ano, François Lucia, Ingrid Masson et al. · PLoS ONE · 2021 · 42 citations · Full text

Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue Sarcoma

Sylvie Bonvalot, Piotr Rutkowski, Juliette Thariat et al. · International Journal of Radiation Oncology*Biology*Physics · 2022 · 41 citations · Full text